LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. (LYRA) Stock Price, Quote, News & History

LYRAOTCEM

Trade with Public

$0.4950

-0.83-62.5%

At close: Mar 13, 5:00 PM EST

OverviewNews Earnings Forecast Price Targets Financials Sentiment Ownership Compare

Key Statistics

Open

$0.50

Volume / Avg.

0 / 12.56K

Day Range

- - -

52 Wk Range

0.00 - 8.75

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

1.66

Recent Lyra Therapeutics Inc News

Gold Rises Sharply; Lyra Therapeutics Shares Plunge

Avi Kapoor

US Stocks Lower; Dow Tumbles Over 250 Points

Avi Kapoor

Upstream's New Sinus Treatment Cuts Need For Surgery, Early Trial Finds

Upstream Bio's Phase 2 trial of verekitug in chronic rhinosinusitis met all endpoints, showing reduced nasal polyps, congestion, and need for surgery.

Vandana Singh

US Stocks Likely To Open Lower: Expert Highlights Technical Analysis Showing S&P 500's 'Recovery Is Real' And Not A 'Bull Trap' Or 'Bear Market Rally'

U.S. stock futures fell on Tuesday after a higher close on Monday. Futures of major benchmark indices declined in premarket.

Rishabh Mishra

Nasdaq Surges Over 100 Points Despite Renewed Trade Concerns: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-28.86M

Investing Cash Flow (TTM)

-98.00K

Financing Cash Flow (TTM)

4.27M

Free Cash Flow (TTM)

-28.98M

Capital Expenditure (TTM)

-116.00K

Net Change in Cash (TTM)

-24.68M

Analyst Rating and Forecast

3.3

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$14.38M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

0.04

PB Ratio (TTM)

Earnings Yield % (TTM)

-186200.00%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

-$6.04

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$15.89M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$0.50

Volume / Avg.

0 / 12.56K

Day Range

- - -

52 Wk Range

0.00 - 8.75

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

1.66

About

Sector

Health Care

Industry

Pharmaceuticals

Lyra Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of anti-inflammatory therapies for the localized treatment of patients with chronic rhinosinusitis, or CRS. Its products include LYR-210 ...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

LYRA

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

LYRA

FAQ

How do I buy LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. (LYRA) stock?

You can purchase shares of LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. (OTCEM:LYRA) through any online brokerage.

View our list of the best stock brokerages

Who are LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. (LYRA) competitors?

There are no as such competitors for LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc..

What is the forecast, or price target, for LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. (LYRA) stock?

LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. has a consensus price target of $9.17.

What is the current price for LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. (LYRA)?

The stock price for LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. (OTCEM: LYRA) is $0.01 last updated August 21, 2026 at 10:58 AM EDT.

Does LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. (LYRA) pay a dividend?

There are no upcoming dividends for LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc..

When is LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. (OTCEM:LYRA) reporting earnings?

LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. does not have any upcoming earnings scheduled.

Is LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. (LYRA) going to split?

There is no upcoming split for LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc..

What sector and industry does LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. (LYRA) operate in?

LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCEM.